# Adolescent idiopathic scoliosis associated POC5 mutation impairs cell cycle, cilia length and centrosome protein interactions

Amani Hassan, Stefan Parent, Hélène Mathieu, Charlotte Zaouter, Sirinart Molidperee, Edward T. Bagu, Soraya Barchi, Isabelle Villemure,

Shunmoogum A. Patten, Florina Moldovan

► To cite this version:

Amani Hassan, Stefan Parent, Hélène Mathieu, Charlotte Zaouter, Sirinart Molidperee, et al.. Adolescent idiopathic scoliosis associated POC5 mutation impairs cell cycle, cilia length and centrosome protein interactions. PLoS ONE, 2019, 14 (3), pp.e0213269. 10.1371/journal.pone.0213269. pasteur-02133010

HAL Id: pasteur-02133010

https://riip.hal.science/pasteur-02133010

Submitted on 17 May 2019

**HAL** is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire **HAL**, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
RESEARCH ARTICLE

# Adolescent idiopathic scoliosis associated *POC5* mutation impairs cell cycle, cilia length and centrosome protein interactions

Amani Hassan¹,², Stefan Parent², Hélène Mathieu², Charlotte Zaouter², Sirinart Molidperee², Edward T. Bagu³, Soraya Barchi², Isabelle Villemure⁴, Shunmoogum A. Patten⁵, Florina Moldovan¹,²*

1 Faculty of Dentistry, Université de Montréal, Montréal, Québec, Canada, 2 CHU Sainte-Justine Research Center, Montréal, Québec, Canada, 3 Department of Basic Biomedical Sciences, Sanford Medical School, University of South Dakota, Vermillion, SD, United States of America, 4 École Polytechnique de Montréal, Montréal, Québec, Canada, 5 INRS–Institut Armand-Frappier, Université du Québec, Laval, Montréal, Québec, Canada

* florina.moldovan@umontreal.ca

<figure><img src="image_2.png" /></figure>

## Abstract

Adolescent Idiopathic Scoliosis (AIS) is a spinal deformity that affects approximately 3 per- cent of human adolescents. Although the etiology and molecular basis of AIS is unclear, several genes such as *POC5* have been identified as possible causes of the condition. In order to understand the role of *POC5* in the pathogenesis of AIS, we investigated the sub- cellular localization of POC5 in cilia of cells over-expressing either the wild type (wt) or an AIS-related POC5 variant POC5A429V. Mutation of POC5 was found to alter its subcellular localization and to induce ciliary retraction. Furthermore, we observed an impaired cell- cycle progression with the accumulation of cells in the S-phase in cells expressing POC5A429V. Using immunoprecipitation coupled to mass spectrometry, we identified spe- cific protein interaction partners of POC5, most of which were components of cilia and cyto- skeleton. Several of these interactions were altered upon mutation of POC5. Altogether, our results demonstrate major cellular alterations, disturbances in centrosome protein interac- tions and cilia retraction in cells expressing an AIS-related POC5 mutation. Our study sug- gests that defects in centrosomes and cilia may underlie AIS pathogenesis.

<figure><img src="image_3.png" /></figure>

### OPEN ACCESS

**Citation:** Hassan A, Parent S, Mathieu H, Zaouter C, Molidperee S, Bagu ET, et al. (2019) Adolescent idiopathic scoliosis associated *POC5* mutation impairs cell cycle, cilia length and centrosome protein interactions. PLoS ONE 14(3): e0213269.
https://doi.org/10.1371/journal.pone.0213269

**Editor:** Hemant Khanna, University of Massachusetts Medical School, UNITED STATES

**Received:** July 23, 2018

**Accepted:** February 19, 2019

**Published:** March 7, 2019

**Copyright:** © 2019 Hassan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

**Data Availability Statement:** All relevant data are within the paper and its Supporting Information files.

**Funding:** This work was supported by: 1. Institut de France (FR), Yves Cotrel Foundation to FM; 2. fonds de Recherche du Québec - Santé (FRQS) to FM; 3. Réseau de Recherche en Santé Buccodentaire et Osseuse (RSBO) to FM; 4. Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) to FM; 5. Scoliosis Research Society (SRS) to FM.

## Introduction

At present, the etiology and biological mechanisms that are involved in the pathogenesis of adolescent idiopathic scoliosis (AIS) remain unclear. Several etiologies and pathways such as neuroendocrine, neurological, muscular, biochemical and structural, hormonal, mechanical and genetic have been suggested to contribute to AIS [1–4]. We previously reported that muta- tions in the centrosomal protein-encoding gene *POC5* are associated with familial idiopathic scoliosis in French Canadian families [5]. The involvement of *POC5* in AIS was further con- firmed in a case-control study, where the *POC5* variant (rs6892146) was found to be associated in individuals with AIS [6].
**Competing interests:** The authors have declared that no competing interests exist.

In humans, the *POC5* gene is on chromosome 5q13 and encodes an ubiquitously expressed protein, abundant in the centrioles where it interacts with centrin and inversin [7]. POC5 is essential for assembling the distal half of the centriole and the elongation of the centrioles [7]. It is also involved in cell functions such as cell polarity, division, motility, and forms part of the cell cytoskeleton that is important for cell dynamics [7–9]. The localization of POC5 within photoreceptors is crucial for ciliary connection and retinal function [10].

Cilia are organelles that extend from the cellular surface of most eukaryotic cells [11]. There are two types of cilia, motile and nonmotile cilium, the latter is also known as primary cilium. Motile cilia are composed of a 9+2 axonemal structure with nine outer microtubule doublets surrounding two centrally located singlet microtubules, and additional accessory structures [10]. Primary cilium are found in almost all eukaryotic cells and are characterized by their 9+0 axoneme organization. They sense and transduce environmental signal and are critical for embryonic and postnatal development, as well as for tissue homeostasis in adulthood [12]. Due to their broad tissue distribution, defects in primary cilia will result in to a broad range of ciliopathies characterized by phenotypic variability and clinical features ranging from renal, retinal, hepatic, musculoskeletal and central nervous system defects [13–16]. Cilia abnormalities were recently associated with scoliosis and defects in the central nervous system [17]. For instance, in zebrafish, mutation of the protein-tyrosine kinase-7 was shown to affect the formation and function of motile cilia in the central nervous system [17] suggested that the ciliary abnormalities caused a disturbance in the flow of cerebrospinal fluid (CSF) leading into spinal curvature. Given the roles of centrosomal proteins in ciliogenesis [18], it is very likely that mutations in POC5 would impact cilia function. However, this hypothesis remains to be explored.

In this study, we investigated the impact of mutations in *POC5* on primary cilia and the subsequent implications in the pathogenesis of AIS. We show that an AIS-related mutation in POC5 induce ciliary retraction and impair cell-cycle. We further demonstrate that mutated POC5 loses its ability to interact with proteins that are important for cilia function as well as cytoskeleton organizations.

# Materials and methods

## Ethical considerations

All human tissue samples were collected in accordance with the policies regarding the ethical use of human tissues for research. The protocol used in this study was approved by the Centre hospitalier universitaire Sainte-Justine Ethics Committee (# 3704).

## Cellular localization of POC5

All cells used in this study were cultured in DMEM media (Wisent cat: 319-015-CL) in an eight-well-chamber glass slide (Fisher scientific cat: 354108). HeLa cells were transfected with either Myc tagged wt-POC5 (Origene cat: RC211731) or POC5<sup>A429V</sup>, (generated by site directed mutagenesis [5]). Following, a 24 hours period post transfection with lipofectamine (Invitrogen, cat: 11668-019), the cells were processed for immunocytochemistry analysis. Briefly, the cells were fixed on ice using 70% ethanol and 0.2% triton, permeabilized with 0.1% triton in PBS (PBT), and then incubated for one hour at room temperature (RT), with rabbit polyclonal POC5 antibody (abcam cat: ab188330, 1/250) and mouse monoclonal acetylated-α-tubulin antibody (Sigma Aldrich cat: T7451 1/2000) diluted in 2% BSA/PBT. After incubation with the primary antibodies, the cells were washed three times with PBT, incubated for one hour at room temperature with secondary antibodies (1/500) Alexa fluor 488 anti-rabbit (life technologies cat: A11008) and Alexa fluor 555 anti-mouse (Life technologies cat: A21422).
Samples were then mounted using prolong gold anti-fade reagent with diamidino-2-phenylindole dye for fixed cells (DAPI) (Life technologies cat: P36931). Confocal fluorescent images were captured using a Zeiss microscope, Z-stack digital imaging was performed in order to reveal more details of the position of POC5 with respect to cilia. The Z-stack technique combines multiple images taken at different focal distances to give a subsequent image with a greater depth of field. Acetylated-α-tubulin (a ciliary marker), POC5 protein and DAPI (the nuclear counterstain) were visualised as red, green, and blue, respectively.

To analyze expression and cellular localization of POC5 at different phases of the cell cycle, HeLa cells were cultured in DMEM Medium (Wisent cat: 319-015-CL) with 10% FBS (Wisent cat: 080-110) and 1% penicillin streptomycin Glutamine (Wisent cat: 50-202-EL) (PSG). When the HeLa cells were confluent, they were serum starved for 24 hours in order to synchronize their cell cycle. Serum starvation was performed by culturing confluent cells in DMEM medium without FBS, supplied with 1% PSG to block in G1 phase. To block cells in S phase, cells were then supplied with DMEM medium with FBS (10%) and 1% PSG for 24 hours. Cells were then examined by double immunofluorescence as described above. Immunofluorescence studies were also performed on normal human osteoblasts and cells carrying POC5 variant mutation c.C1286T (p.A429V). Tissue samples were collected for mutation analysis of the osteoblasts from patients with scoliosis during surgery. Genomic DNA was extracted from cells using pure link genomic DNA mini kit (cat: k 1820-01). Polymerase chain reaction was performed for exon 10 using primers: Forward: 5' CTTTTCATAAGGTGGGACC T3' Reverse: 5' TCCGATGCCCTTACCAG3'. Bands corresponding to the correct molecular weight of POC5 were excised from gel and purified using GenElute Gel extraction kit (Cat: NA1111-1KT). The purified DNA amplicons were then sequenced (University McGill and Génome Québec Innovation Centre, Montréal QC).

## Preparation of nuclear and cytoplasmic extracts

Cells were washed with 4 ml of PBS (1x) and then harvested in PBS by scraping. The lysate was collected in eppendorf tube and spun for 5 minutes in a microcentrifuge at low speed (4000 rpm). Pellet was washed twice with 500 µl of buffer A (Hepes 10mM, KCl 10mM, DTT 0.5mM)(w/o NP-40) and then cell pellet was resuspended in 20 µl of buffer A (w/ NP-40 (1%)) and incubated at 4°C for 10 minutes with rocking. The cell pellet was spun down in microcentrifuge for 2 minutes at max speed. The supernatant is the cytoplasmic extract (C extract) by adding 55 µl of buffer C and stored at -80°C. The nuclear extract was resuspended in 55 µl of buffer C (Hepes 20 mM, glycerol 20%, KCl 500 mM, EDTA 0.2 mM, PMSF 0.5 mM, DTT 0.5 mM and MgCl2 1.5mM); and incubated at 4°C for 15 minutes with rocking. The nuclei were then spun in microcentrifuge for 5-10 minutes at max speed. At this stage, the supernatant is the nuclear extract (N extract).

## Immunoprecipitation coupled to mass spectrometry (IP-MS), co-Immunoprecipitation and Western blot

To identify specific protein-protein interaction partners of POC5, immunoprecipitation coupled to mass spectrometry, co-immunoprecipitation, and Western Blot analysis was performed on HEK293 cells transfected with wt or POC5A429V expressing vectors. HEK293 cells were cultured in DMEM medium (Wisent cat: 319-015-CL) with 10% FBS and 1% PSG. When confluent, cells were transfected using lipofectamine 2000 (Invitrogen cat: 11668027) with control (mock-myc empty vector), Myc tagged wt or POC5A429V expressing vectors. For transfection, cells were maintained in antibiotic free medium overnight. On the second day, cells were transfected based on the lipofectamine protocol provided by the manufacturer (Invitrogen).
For protein extraction, cells were lysed in IP lysis buffer (Pierce Thermoscientific, cat: 87787) supplied with 1 x protease inhibitor cocktail (Roche cat: 04693116001). Lysate was then centrifuged for 15 minutes at 8000 rpm. Supernatant was collected for protein quantification by Bradford (Bradford Biorad cat: 500-0006). For immunoprecipitation, 3000 µg of proteins were immunoprecipitated with 2.5 µg/ml of anti-myc antibody (Origene, cat: TA15021) overnight (ON) at 4°C. Magnetic beads (Biorad cat: 161-4023) were washed with PBS and blocked using 2% BSA/PBS (BSA from Sigma-Aldrich cat: A7906) ON at 4°C. On the second day, beads were washed 3 x with PBS and then incubated with protein lysate and antibody complex at 4°C ON. On the third day, the flow through was collected and the beads were heated for 10 minutes in laemmeli 2 x (biorad cat: 161-0737) at 55°C. Protein samples and dual plus molecular weight ladders (Bio-rad cat: 161-0374) were separated by SDS-PAGE approximately 90 minutes at 100 Volts in running buffer (25 mM Tris base, 192 mM glycine, 1% SDS, pH 8.3). The gel was stained with Coomassie blue (Biorad cat G-250 #1610406) for 3 hours. After staining the gel with Coomassie blue, the bands corresponding to the molecular size of POC5 (63 kDa) were excised and analyzed by mass spectroscopy. The gels were subjected to trypsin digestion then an aliquot of the tryptic digest (prepared in 5% acetonitrile/ 0.1% trifluoroacetic acid in water) was analyzed by LC-MS on an LTQ-Orbitrap mass spectrometer system (ThermoElectron) coupled to a Dionex 3000 nano-LC system (Camberley). Mass spectroscopy analysis was evaluated using scaffold software [19]. Mass Spectroscopy was performed at the Mass spectroscopy plateform at the Institute of Research in Immunology and Cancer (IRIC).

In parallel, an aliquot of protein samples was transferred to nitrocellulose membranes (Bio-Rad cat: 9004700) and ran 90 min at 90 V and 250 mA. The total proteins on membranes were detected with Ponceau S staining (Sigma cat: P3504). Membranes were blocked with 20% non-fat milk (Santa-Cruz cat: Sc2324) in PBST (10 mM phosphate, 137 mM NaCl, 2.7 mM KCl, containing 0.05% Tween-20, pH 7.4) for 1 hour and then incubated with anti-POC5 antibody in PBST with 5% BSA in PBT at 4°C ON. The secondary antibody was (anti-rabbit IgG secondary antibody (Thermoscientific cat: 31460) diluted at 1: 10000 for one hr at RT. In order to validate the mass spectroscopy data, and confirm the interaction of several ciliary proteins with POC5, Western blot was performed by stripping the same membrane with a Restore stripping buffer (Thermofisher cat: 21059) and probing it with different antibodies. The following antibodies were used Annexin2 (sc-374394), Galectin 3 and 7 (sc-32790 and sc-137085), CKAP5 (sc-374394), Desmocollin1 (sc-398590), CEP290 (ab84870), Septin9 (sc-293291), Acetylated-α-tubulin (Sigma Aldrich cat# T7451 1/2000), RAB11 (ab3612), EHD4 (sc-376373), Annexin5 (sc-32321), and CystatinA (sc-376759). All antibodies acquired from Santa Cruz (Sc) were mouse monoclonal and used at a dilution of 1/500. Rabbit polyclonal antibodies CEP290 and Rab11 were used at a dilution of 1/250. The secondary antibody (anti-rabbit IgG secondary antibody (Thermoscientific cat: 31460) was diluted 1:10000, and anti-mouse IgG secondary antibody (Thermoscientific cat: 31430) was diluted 1:10000 for 1 hour at RT. Membranes were exposed to ECL prime Western blotting detection reagent (GE healthcare cat: RPN2232) for 5 minutes at RT room.

## Immunoprecipitation phosphatase assay

HEK293 cells were transfected with wtPOC5 myc tagged or POC5<sup>A429V</sup> myc tagged vectors (as described above) and then were synchronized at G1 or S phases. To block cells at G1 phase, cells were serum starved for 24 hours. To block cells at S phase, cells were first starved for 24 hours and then complete medium with serum (10% FBS) was added for 24 hours. For immunoprecipitation-phosphatase assays, total lysates were incubated with 2.5 µg anti-myc antibody as described above. Beads were blocked with 1% BSA and then washed three times and
resuspended in 100 µl PBS. Then, protein antibody complex were incubated with beads. Alka-
line phosphatase (NEB cat: M0290S) was added to the mixture and incubated at 37°C for 1
hour. Western blot was performed using POC5 antibody (Abcam cat: 188330) as described
above.

**Quantification and statistical analysis**

The length of cilia was quantified using ImageJ by measuring the acetylated-α-tubulin signals [20]. For ciliation experiments with NOB and AIS cells, approximately 300 cilia were counted per experiment. For cell cycle analysis, the number of cells in S phase and G1 phase were counted. The percentage of cells in each phase over the number of total cells was determined. Approximately 100 cells were counted per phase. Mean values of individual experiments were plotted in bar graphs with ±SD between the individual sets. P-values were calculated by one-way analysis of variance (ANOVA). P<0.05 considered statistically significant.

Results

Altered subcellular localization of POC5 upon mutation

We first examined the subcellular distribution of wild-type human *POC5* (wt*POC5*) and an AIS-related mutant *POC5*<sup>A429V</sup> (mut*POC5*) in HeLa cells. HeLa cells are p53-defective cell lines and hence they do not arrest at G1 phase after the disruption of centrosomal proteins, unlike non-transformed cells that are arrested at G1 through p53 dependent pathway upon depletion of centrosomal proteins. The centriolar cycle of HeLa cells is well described [21, 22]. For HeLa cell to progress through its life cycle, centriolar replication and pericentriolar changes occurs in synchrony with DNA synthesis and mitosis. Since POC5 localization and function has been well characterized in HeLa cells [7], we sought to first investigate the cellular effects of POC5 mutations in the HeLA cells.

In wt POC5 cells, POC5 was found to localize to the acetylated-α-tubulin ring (Fig 1A). On the other hand, POC5 was mislocalized in POC5<sup>A429V</sup> cells (Fig 1B).

Aberrant POC5 localization in osteoblasts derived from AIS patients
bearing the POC5<sup>A429V</sup> mutation

To confirm our observation in HeLa cells, we next investigated the effects of POC5 mutation on the subcellular localization by comparing normal (non-scoliotic) to osteoblasts derived from AIS patients carrying the *POC5*<sup>A429V</sup> variant (Fig 2). In normal control osteoblasts, POC5 expression was colocalized with acetylated-α-tubulin stainings, suggesting that centriolar protein POC5 is located at the cilium (Fig 2A–2D). In AIS osteoblasts, POC5 was rather located within the nucleus and not colocalized with acetylated-α-tubulin stainings (Fig 2E–2H). Furthermore, a retraction of cilium was observed in *POC5*<sup>A429V</sup> osteoblasts (Fig 2H) compared to controls. More precisely, quantification of the ciliary length showed that *POC5*<sup>A429V</sup> cells predominantly had shorter cilium of more than 3µm than that of control cells (Fig 2I). Altogether, these results suggest that mutations in POC5 affect its subcellular localization with respect to the cilium.

Defects in cell-cycle progression in cells overexpressing the mutPOC5

Because POC5 is localized to the distal portion of centrioles and is recruited to procentrioles for full centriolar maturation and normal cell-cycle progression, we next determined how *POC5*<sup>A429V</sup> protein is localized during cell cycle progression. HeLa cells transfected with either wt or *POC5*<sup>A429V</sup> were synchronized in the growth phase (G1) cell cycle phase and then stained
<figure><img src="image_4.png" /><figcaption>**Fig 1. Differential localization of POC5 with acetylated-α-tubulin in wtPOC5 and POC5<sup>A429V</sup> expressing cells.**
Confocal imaging of HeLa cells transiently transfected with wtPOC5 (a) or POC5<sup>A429V</sup> (b). POC5 and acetylated-α-tubulin were determined using specific antibodies and positive signal revealed by green and red coloration respectively. Localization of POC5 with respect to acetylated-α-tubulin is shown: in cells transfected with wtPOC5 (a) where positive immunostaining was enriched at the perinuclear acetylated-α-tubulin ring, while in cells expressing POC5<sup>A429V</sup> (b), POC5 was visualized inside the nucleus (disconnected from the perinuclear acetylated-α-tubulin ring). The Z-stack imaging (recording images at different focal planes) allows the visualization of the three-dimensional structure containing both POC5 and acetylated-α-tubulin (green and red) for the wtPOC5, while only POC5 (green) was visualized for the POC5<sup>A429V</sup>. Images were taken using the Zeiss microscopy Mag x40. Scale bar 1.6 µm. POC5 in green, acetylated-α-tubulin in red and DNA was stained with DAPI (blue).</figcaption></figure>

https://doi.org/10.1371/journal.pone.0213269.g001

<figure><img src="image_5.png" /><figcaption>**Fig 2. Human osteoblasts carrying POC5<sup>A429V</sup> show short cilia.** Representative immunodetection of POC5 and acetylated-α-tubulin by immunofluorescence in osteoblasts from normal (non scoliotic) (a, b, c, d) and cells with the POC5<sup>A429V</sup> (e, f, g, h). Merged images (d and h) show differential colocalization of POC5 with respect to cilia. Zoomed image shows that POC5 is located at the cilium level marked by acetylated-α-tubulin. Human osteoblasts carrying the variant POC5<sup>A429V</sup> (e, f, g, h), show decreased staining intensity and absence or retraction of cilium (h). POC5<sup>A429V</sup> protein was seen to be localized within the nucleus (zoomed image). POC5 (green coloration), acetylated-α-tubulin (red coloration) and the nucleus were stained with DAPI (blue). Images were taken using the Zeiss microscopy. Mag x 40. Scale bar 1.6 µm. (I) The graphs represent the percentage of cilia for each length category in NOB and AIS cells (POC5<sup>A429V</sup>). Each bar represents the mean of three independent experiments (±SD). P< 0.05 considered statistically significant. (J) Sequence alignment with Sanger sequencing confirm AIS cells to have the POC5<sup>A429V</sup> mutation.</figcaption></figure>

https://doi.org/10.1371/journal.pone.0213269.g002
<figure><img src="image_6.png" /><figcaption>**Fig 3.** *POC5*<sup>A429V</sup> expressing cells are arrested in S phase. Confocal imaging of HeLa cells overexpressing wtPOC5 or *POC5*<sup>A429V</sup> specific staining for POC5 was performed using POC5 antibody. During G1 phase, obtained by serum starvation (a), wtPOC5 is located within the cytoplasm, while in the S phase (b) (serum replacement after deprivation), POC5 is located within the nucleus. WtPOC5 expressing cells have normal progression through G1 and S phases, (a, b). In the cells overexpressing *POC5*<sup>A429V</sup>, POC5 is located within the nucleus in both G1 and S phases (c, d). Cells are blocked in S phase and unable to progress through the cell cycle. E) The graphs represent the percentage of cells in G1 of S phase. Almost all wtPOC5 expressing cells are in G1 phase (45%), but *POC5*<sup>A429V</sup> cells are accumulating in S phase. Each bar represents the mean of three independent experiments (±SD). P<0.05 considered statistically significant. Images were taken using the Zeiss microscopy. POC5 (visualized in red), DNA was stained with DAPI (blue). Mag x 40. Scale bar 1.6 µm.</figcaption></figure>

https://doi.org/10.1371/journal.pone.0213269.g003

for POC5. In cells transfected with wtPOC5, POC5 protein was observed outside the nucleus during the G1 phase (Fig 3A) and in the nucleus during the Synthesis (S)-phase (Fig 4B). However, in *POC5*<sup>A429V</sup> expressing cells, POC5 was found to be rather localized in the nucleus through the G1 and S phases (Fig 3C and 3D). Interestingly, a significant increase (4%) in the proportion of S-phase cells was detected in *POC5*<sup>A429V</sup> cells compared to wtPOC5 cells (Fig 3E). To confirm this observation, we performed cellular fractionation of cytoplasmic and nuclear extracts of cells overexpressing wt or *POC5*<sup>A429V</sup>. The wtPOC5 was concentrated in both nuclear and cytoplasmic fractions with higher expression levels in the cytoplasm. Contrary to wtPOC5, the *POC5*<sup>A429V</sup> was exclusively found in the nucleus (Fig 4).

In order to check if the differential recruitment of wtPOC5 and *POC5*<sup>A429V</sup> variant to the cilium is phosphorylation-dependent, we studied the pattern of phosphorylation of wt and *POC5*<sup>A429V</sup> during the cell cycle progression. We found that the *POC5*<sup>A429V</sup> was hyper phosphorylated independently of the phase of the cell cycle. In all cell cycle phases, the *POC5*<sup>A429V</sup> protein had lower migration level than wtPOC5 protein and treatment with alkaline phosphatase shifted back *POC5*<sup>A429V</sup> to an apparent molecular weight similar to wtPOC5 levels (S2 Fig).

## POC5 interacting protein partners are mostly ciliary and cytoskeletal proteins

To gain a better understanding of the centrosome and cilium protein interaction landscape in AIS, mass spectrometry studies were conducted in cells transfected with either the wtPOC5 or *POC5*<sup>A429V</sup> cells following myc-tagged POC5 pull-down assays. Immunoprecipitation of POC5 showed similar expression levels of POC5 in both wt and *POC5*<sup>A429V</sup> transfected samples (Fig 5A). We identified 85 proteins that interact predominantly with wtPOC5 but not *POC5*<sup>A429V</sup> (Table 1) and only 5 proteins interacting with *POC5*<sup>A429V</sup> (Table 2). Amongst these
A

WB: cell lysate

<figure><img src="image_7.png" /></figure>

B

IP: anti-myc

WB:

<figure><img src="image_8.png" /></figure>

<figure><img src="image_9.png" /></figure>

**Fig 4.** Validation of mass spectrometric results. Proteins identified by mass spectroscopy interacting with the wtPOC5 were analysed by CO-IP. Coimmunoprecipitation of myc-POC5 using anti-Myc antibodies in Hek293 cells. Proteins in the immune complexes were revealed by Western blotting with different antibodies as described in materials and methods. Control (cells transfected with Mock pCMV-entry vector) was used along cells transfected with
myc tagged wt or *POC5*<sup>A429V</sup> expressing cells. A) Western blot on total cell lysate using POC5 antibody. Wt and *POC5*<sup>A429V</sup> transfected cells have same expression levels of POC5. Mock transfected sample has very low expression of POC5. POC5 is observed at the expected size 63kDa in the wtPOC5 and at higher level in *POC5*<sup>A429V</sup> (indicated as p: phosphorylated). B) CO-IP shows the binding of Annexin2, Annexin 5, Desmocollin1 and CEP290, exclusively with wtPOC5. Very weak interaction was observed between POC5<sup>A429</sup> with Acetylated-α-tubulin, Galectin3 and 7, EHD4, CystatinA compared to wtPOC5.

https://doi.org/10.1371/journal.pone.0213269.g004

proteins, we identified 12 ciliary and cytoskeletal proteins that have altered interaction with POC5 when mutated. For instance, Annexin2, Desmocollin1 and Centrosomal protein 290kDa (CEP290) were found to interact with wtPOC5, but not with *POC5*<sup>A429V</sup> (Fig 5B). Weaker interactions between POC5 and Galectin 3, Galectin 7, Acetylated-α-tubulin, EH domain-containing protein 4 (EHD4), Annexin5 and Cystatin A were observed in cells expressing *POC5*<sup>A429V</sup> compared to wtPOC5 (Fig 5B and S1B Fig). Protein disulfide-isomerase A4, iduronate 2-sulfatase, golgi resident protein GCP60, aminopeptidase B, cDNA FLJ53442— highly similar to poly (ADP-ribose) polymerase 1 were found a new interactors of POC5 upon mutation (Table 2). These findings suggest that an altered centrosomal and cilia protein inter- action may be involved in AIS.

<figure><img src="image_10.png" /><figcaption>**Fig 5.** Differential colocalization of wtPOC5 and *POC5*<sup>A429V</sup> with respect to centrin. A) Immunofluorescence staining was performed in HeLa cells non-transfected (NT) overexpressing pCMV-entry empty vector (mock), wtPOC5 or *POC5*<sup>A429V</sup>. Staining of POC5 (red), centrin 2 (green) shows colocalization of wtPOC5 and centrin 2 (merge orange colour), and absence of colocalization with *POC5*<sup>A429V</sup> and centrin 2. B) Statistical analysis of centrin 2 expression, intensity and number of centrin foci per cell in mock, wtPOC5 and *POC5*<sup>A429V</sup> expressing HeLa cells. Percentage of centrin 2 number and intensity are reduced in *POC5*<sup>A429V</sup> expressing cells. Unlike wtPOC5 cells, most *POC5*<sup>A429V</sup> cells have one foci of centrin but majority of wtPOC5 expressing cells have two foci of centrin 2. Centrin count and intensity was performed using ZEN software. Images (n = 6) were used for quantification. Error bars are the mean ± SD. p<0.05 considered statistically significant. POC5 (red), centrin (green) and DAPI (blue). NT: not transfected. NS: not significant.</figcaption></figure>

https://doi.org/10.1371/journal.pone.0213269.g005
<table><caption>**Table 1.** Mass spectroscopy results of proteins interacting exclusively with wtPOC5. Scaffold software was used for the analysis of the identified proteins interacting with wtPOC5. Protein identification in wtPOC5 expressing cells, detected 85 candidates interacting with wtPOC5. Clustering proteins by biological function indicated: ciliary proteins (17 proteins); cell adhesion (7 proteins); cytoskeleton-associated protein (4 proteins); RNA processing (9 proteins); extracellular matrix (3 proteins); response to estrogen (1 protein); cell cycle and cytokinesis (1 protein). Most of the identified proteins interacting with POC5 are cytoskeletal proteins (As shown in the table) and those marked in bold were considered for further analysis. Other protein groups belong to cell cycle and cytokinesis, extracellular proteins, RNA processing, cell adhesion, and response to estrogen.</caption><thead><tr><th>Protein ID</th><th>Description</th><th>Score</th><th>Peptide Number</th></tr></thead><tbody><tr><td>P15924</td><td>Desmoplakin</td><td>3984</td><td>119</td></tr><tr><td>Q08554</td><td><strong>Desmocollin-1</strong></td><td>581</td><td>12</td></tr><tr><td>P68363</td><td><strong>Tubulin alpha-1B chain</strong></td><td>368</td><td>10</td></tr><tr><td>P07355</td><td><strong>Annexin A2</strong></td><td>221</td><td>9</td></tr><tr><td>Q9NSK0-3</td><td>Isoform 3 of Kinesin light chain 4</td><td>155</td><td>9</td></tr><tr><td>F8VW92</td><td>Tubulin beta chain</td><td>251</td><td>7</td></tr><tr><td>P47929</td><td><strong>Galectin-7</strong></td><td>338</td><td>6</td></tr><tr><td>Q9H223</td><td><strong>EH domain-containing protein 41</strong></td><td>62</td><td>4</td></tr><tr><td>Q6IB90</td><td><strong>Cystatin</strong></td><td>84</td><td>3</td></tr><tr><td>Q9NZT1</td><td>Calmodulin-like protein 5</td><td>243</td><td>3</td></tr><tr><td>Q14574-2</td><td>Isoform 3B of Desmocollin-3</td><td>63</td><td>3</td></tr><tr><td>Q14008</td><td><strong>Cytoskeleton-associated protein 5</strong></td><td>57</td><td>3</td></tr><tr><td>Q9Y5P4-2</td><td>Isoform 2 of Collagen type IV alpha-3-binding protein</td><td>45</td><td>2</td></tr><tr><td>P27482</td><td>Calmodulin-like protein 3</td><td>144</td><td>2</td></tr><tr><td>P08758</td><td><strong>Annexin A5</strong></td><td>164</td><td>2</td></tr><tr><td>Q08380</td><td>Galectin-3-binding protein</td><td>76</td><td>2</td></tr><tr><th>Protein ID</th><th>Description</th><th>Score</th><th>Peptide Number</th></tr><tr><td>B4DF70</td><td>cDNA FLJ60461; highly similar to Peroxiredoxin-2 (EC 1.11.1.15)</td><td>88</td><td>2</td></tr><tr><td>Q59FR8</td><td><strong>Galectin 3</strong></td><td></td><td>2</td></tr><tr><td>Q9UHD8-5</td><td><strong>Isoform 5 of Septin-9</strong></td><td>46</td><td>2</td></tr><tr><td>J3KNF5</td><td><strong>Centrosomal protein of 290 kDa</strong></td><td>20</td><td>1</td></tr><tr><td>Q8N6N5</td><td>Tubulin; beta 2C</td><td>85</td><td>1</td></tr><tr><td>B4E0R6</td><td>Importin-5</td><td>69</td><td>1</td></tr><tr><td>Q86YS3-2</td><td><strong>Isoform 2 of Rab11 family-interacting protein 4</strong></td><td>27</td><td>1</td></tr><tr><td>A8MUB1</td><td><strong>Tubulin alpha-4A chain</strong></td><td>183</td><td>1</td></tr><tr><td>A9X9K9</td><td>Desmocollin 2</td><td>46</td><td>1</td></tr><tr><td>r-Q5T802</td><td>RUNX2</td><td>15</td><td>1</td></tr><tr><td>Q13835</td><td>Plakophilin-1 2</td><td>536</td><td>17</td></tr><tr><td>F5GWP8</td><td>Junction plakoglobin</td><td>3102</td><td>16</td></tr><tr><td>P25311</td><td>Zinc-alpha-2-glycoprotein</td><td>141</td><td>3</td></tr><tr><td>Q9GZZ8</td><td>Extracellular glycoprotein lacritin</td><td>98</td><td>3</td></tr><tr><td>E9PBV3</td><td>Suprabasin</td><td>190</td><td>3</td></tr><tr><td>Q9Y5P4-2</td><td>Isoform 2 of Collagen type IV alpha-3-binding protein</td><td>45</td><td>2</td></tr><tr><td>B4DT31</td><td>Far upstream element-binding protein 1</td><td>151</td><td>9</td></tr><tr><td>E9PIN3</td><td>Nuclear RNA export factor 1 (Fragment)</td><td>149</td><td>5</td></tr><tr><td>O43776</td><td>Asparagine—tRNA ligase; cytoplasmic</td><td>94</td><td>4</td></tr><tr><td>Q9Y2X3</td><td>Nucleolar protein 58</td><td>113</td><td>4</td></tr><tr><td>B8ZZD1</td><td>U4/U6.U5 tri-snRNP-associated protein 2</td><td>43</td><td>2</td></tr><tr><td>P35579</td><td>Myosin-9</td><td>555</td><td>18</td></tr><tr><td>P58107</td><td>Epiplakin</td><td>200</td><td>10</td></tr><tr><td>Q8WVV4</td><td>Protein POF1B</td><td>242</td><td>6</td></tr><tr><td>Q15149-9</td><td>Isoform 9 of Plectin</td><td>84</td><td>2</td></tr></tbody></table>

https://doi.org/10.1371/journal.pone.0213269.t001
<table><caption>**Table 2.** Mass spectroscopy results of proteins interacting exclusively with POC5<sup>A429V</sup>. Five proteins were found to be interacting exclusively with POC5<sup>A429V</sup>. Protein disulfide-isomerase A4, Iduronate 2-sulfatase, Golgi resident protein GCP60, Aminopeptidase B and cDNA FLJ53442; highly similar to Poly (ADP-ribose) polymerase.</caption><thead><tr><th>Protein ID</th><th>Description</th><th>Score</th><th>Peptide Number</th></tr></thead><tbody><tr><td>P13667</td><td>Protein disulfide-isomerase A4</td><td>226</td><td>9</td></tr><tr><td>P22304</td><td>Iduronate 2-sulfatase</td><td>138</td><td>5</td></tr><tr><td>Q9H3P7</td><td>Golgi resident protein GCP60</td><td>193</td><td>3</td></tr><tr><td>Q7RU04</td><td>Aminopeptidase B</td><td>95</td><td>2</td></tr><tr><td>B4E0E1</td><td>cDNA FLJ53442; highly similar to Poly (ADP-ribose) polymerase 1</td><td>61</td><td>2</td></tr></tbody></table>

https://doi.org/10.1371/journal.pone.0213269.t002

## WtPOC5 but not POC5<sup>A429V</sup> colocalizes with centrin

Localization of hPOC5 and centrin during the cell cycle has previously been described in literature [7]. To precisely localize POC5 and to study the consequence of mutation on POC5 recruitment to cilia, we performed double immunostaining for POC5 and centrin in cells over-expressing wtPOC5 or POC5<sup>A429V</sup>. In immunofluorescence microscopy, anti-hPOC5 antibody staining labeled two foci for wtPOC5 and one foci for POC5<sup>A429V</sup>. These foci represent centrioles, as confirmed by colocalization with human centrin (Fig 6A). Quantification of centrin percentage per cell revealed that there is significantly higher centrin staining intensity in wtPOC5 expressing cells than POC5<sup>A429V</sup> cells and that the POC5<sup>A429V</sup> expressing cells had mainly one or more than two centrin foci compared to wtPOC5 cells which had predominantly 2 foci (Fig 6B).

## Discussion

In this study, we demonstrated that the mutation in POC5<sup>A429V</sup>, previously described in patients with AIS [5], resulted in an altered subcellular localization of POC5 both in transfected and clinically-relevant patients cells. We also showed that several cilia, microtubules, cytoskeleton, and centrosomal proteins interact with POC5 and many of which are lost with an AIS-related POC5 mutation. We further found an impaired cell cycle progression and ciliary retraction in cells expressing POC5<sup>A429V</sup> compared to controls (Fig 7).

In French families with AIS, various functional variants (c.G1336A (p.A446T), c.G1363C (p. A455P), and c.C1286T (p.A429V)) are contributing to the occurrence of AIS [5]. Recently, a common variant of POC5 was associated with the susceptibility to AIS (single-nucleotide polymorphism (SNP) rs6892146)) in Chinese population [6]. This common SNP has a

<figure><img src="image_11.png" /><figcaption>**Fig 6.** Differential subcellular localization of wtPOC5 and POC5<sup>A429V</sup>. Nuclear and cytoplasmic cell extracts were obtained using protocol as described in materials and methods. Equal nuclear and cytoplasmic protein samples loaded were determined using β-actin as loading control and subjected to immunoblotting using anti-POC5 antibody. Controls were cells non transfected or transfected with pCMV-entry vector. The wtPOC5 is mainly expressed in the cytoplasm and the POC5<sup>A429V</sup> is mostly nuclear. The results are from two independent experiments (n = 2).</figcaption></figure>

https://doi.org/10.1371/journal.pone.0213269.g006
<figure><img src="image_12.png" /><figcaption>**Fig 7.** Proposed model for the mechanisms of ciliary retraction in POC5<sup>A429V</sup> expressing cells. Under normal conditions, POC5 is an essential protein for normal cell cycle progression, and this process is a tightly regulated mechanism. In cycling cells, with wtPOC5, POC5 protein is found interacting with several ciliary proteins that assemble before entering to G1 phase. Weak or no interaction of POC5<sup>A429V</sup> with ciliary proteins (revealed in this study by immunofluorescence, mass spectroscopy, and CO-IP) results in incorrect assembly and cilium retraction.</figcaption></figure>

https://doi.org/10.1371/journal.pone.0213269.g007

significantly different distribution of minor allele frequency in patients with the GG and with CC genotype. Interestingly, in patients with the GG genotype, POC5 mRNA expression was found to be significantly increased when compared to the controls [6]; however, little is known about the function of POC5 and its role in AIS pathologies. The POC5 variant, POC5<sup>A429V</sup> is a rare variant that was found in AIS patients [5].

In addition to the association of POC5 with AIS [5], recently, new mutations in POC5 gene were associated with Retinitis Pigmentosa (RP) [10]. Retinitis Pigmentosa is a photoreceptor degenerative disease, characterized by the degeneration of rod and cone photoreceptors and is classified as ciliopathy disease. Weisz et al [10] reported POC5 to be localized at the connection cilia in the photoreceptors, and when mutated, the length of photoreceptor outer segments is reduced. In our *in vitro* work, in cells overexpressing POC5<sup>A429V</sup>, POC5 was not co-localized with the acetylated-α-tubulin (Fig 1B), dispatched from centrin (Fig 5) and solemnly localized in the nucleus (Fig 6). In contrast, the wtPOC5 was found to be interacting with several ciliary proteins (Table 1). We point out to a role of POC5 as a ciliary protein that is located at the base of the cilium as was confirmed by centrin staining (Fig 5).

Our immunofluorescence results showed also a differential localization of wt and POC5<sup>A429V</sup> with respect to the centrin (Fig 5). Our mass spectroscopy and co-IP data (Fig 4) showed several ciliary proteins to be interacting exclusively with wtPOC5 but not POC5<sup>A429V</sup>.
Among these two proteins component of cilia were found; RAB11 and CEP290. Protein RAB11 is part of the multiple GTPases group that include RAB6, RAB11, and RAB8A which are involved in the trafficking to the cilium. Interestingly, several disorders associated with genetic mutations encoding defective proteins of cilia formation or function showed scoliosis as a secondary manifestation. Some studies have shown that the potential handover mechanisms may exist between RAB11 and RAB8 at the base of the cilium [23]. Rab8 and Rab11 were found to be associated with the Bardet-Beidl syndrome (BBS) pathway [24]. CEP290 is also known to be an important component of the primary cilium, localizing to the Y-links of the ciliary transition zone and having a role in the regulation of transport in and out of the ciliary compartment [25]. Furthermore, CEP290 mutations lead to a range of ciliopathy syndromes with variable clinical manifestations in humans: BBS, Joubert syndrome and Meckel-Gruber syndrome [26]. Given that both proteins (POC5 and CEP290) are located at the base of the cilium (as also confirmed in this study by centrin immunostaining), and that CEP290 interacts solely with wtPOC5, this supports the role of POC5 as a ciliary protein operating at the base of the cilium.

Interestingly, two proteins previously associated with scoliosis, Annexin A2 and Calmodulin were found to interact with wtPOC5 were previously associated with scoliosis. Annexin A2, is highly expressed in osteoblasts, and differentiated growth plate chondrocytes and plays an essential role in bone mineralization which appears to be critical in AIS patients. Calmodulin-like protein 3 (immunoprecipitated with wtPOC5 but not POC5<sup>A429V</sup>) is another interesting putative protein partner of POC5 in AIS. Calmodulin-like protein is a calcium sensor protein that is closely related to the ubiquitous calmodulin, which is considered potential key molecule in the etiology of scoliosis because of its effects on muscle contractility, that was reported defective in AIS patients [27] (Table 1). Only five proteins were found to be associated with mutPOC5 protein 5. Interestingly, among those proteins is iduronate 2-sulfatase. Iduronate 2-sulfatase is associated with Hunter syndrome clinical disorder (mucopolysaccharidosis type II, MPS-II) in which patients may display, scoliosis [28, 29]. Also, the cellular stress gene protein disulfide isomerase (PDIA4) was found to be associated with POC5<sup>A429V</sup>. PDIA4 is up-regulated in mouse models of brain neurodegenerative diseases involving protein misfolding. Although not much is known about the physiological role of PDIA4, studies indicate that this gene is upregulated following endoplasmic reticulum ER stress [30, 31]. Another interesting observation was the hyper-phosphorylation of the POC5<sup>A429V</sup> (S2 Fig). It is well known that posttranslational modifications are one of the ways to regulate protein activity, subcellular localization, and stability [32]. Further studies are needed to determine where exactly the phosphate group is added and the accurate consequences on the physico-chemical properties, stability, kinetics, and dynamics [32].

One of the most intriguing results of our study was the immunofluorescence on human cells carrying the POC5 variant (c.C1286T; p.A429V mutation) showing the subcellular mislocalization of POC5. We observed ciliary retraction in scoliotic osteoblasts (Fig 2H) with the POC5<sup>A429V</sup> mutation (Fig 2H) when compared to the normal osteoblasts (Fig 2D). The primary cilium is an antenna-like projection of the cell that plays a critical role in the perception and integration of environmental signals like mechanotransduction. Cilia are also essential for left-right (L-R) symmetry during embryonic development [33, 34] and for cerebrospinal fluid (CSF) flow [35]. Motile cilia dysfunction may cause spinal deformity similar to the IS [17] and restoration of motile cilia activity stopped spinal curve progression, as evidenced recently in a zebrafish model [17]. This observation supports our results that show a defect in cilia organization as well as perturbed localization of POC5 with respect to the cilia in cells expressing a POC5 mutation (Fig 2H). Another interesting observation is the defect in the cell cycle in POC5<sup>A429V</sup> overexpressing cells. The cells were synchronized to be at the same cell cycle stage,
and a different subcellular localization of wt and POC5<sup>A429V</sup> at different stages of the cell cycle was observed. Not only the cellular localization of POC5 but also the number of centrin foci were used to confirm the accumulation of POC5<sup>A429V</sup> in S phase (>2 foci of centrin) [7, 36]. The POC5<sup>A429V</sup> was permanently located within the nucleus in G1 and S phases (Fig 3C and 3D). By cellular fractionation, we confirmed the different subcellular localization of wt and POC5<sup>A429</sup> (Fig 6). Previous work [7] also showed that a depletion of POC5 in HeLa cells affects the progression through S phase. Human h-POC5-depleted cells had a significant increase in the proportion of S-phase cells; thus, hPOC5 depletion induced an accumulation of cells in S phase where procentriole assembly was probably initiated; however, these procentrioles failed to elongate. The cilia and neurosensory component of this pathology merits further investigation through various functional tests in patients with AIS in order to evaluate the possible functional defect connected with the altered structures identified in this work. Further study, focused on the primary cilia-mediated function, will provide more insight into the molecular mechanisms and etiology of AIS.

## Conclusion

This work identified specific protein interaction partners of POC5 and revealed that POC5<sup>A429V</sup> alters the interaction with several ciliary and cytoskeletal proteins. Improved interaction of POC5<sup>A429V</sup> with ciliary proteins resulted in the loss of POC5 co-localization with acetylated-α-tubulin, impaired cell cycle progression and cilium retraction. These findings open new avenues for the understanding the role of POC5 in AIS at the molecular and cellular levels and suggest that centrosomes and cilia may underlie AIS pathogenesis

## Supporting information

S1 Fig. Acetylated-α-tubulin is highly enriched in precipitated wtPOC5 lysate but not POC5<sup>A429V</sup>. Hek293 cells were transfected with empty pCMV entry vector, wtPOC5 or POC5<sup>A429V</sup> myc tagged vectors. Immunoprecipitation of POC5 was performed using myc antibody (origene). A) Western blot of acetylated-α-tubulin after immunoprecipitation of POC5, shows high expression of acetylated-α-tubulin in the wtPOC5 expressing sample and lower levels in POC5<sup>A429V</sup>. Very low levels are observed in mock transfected sample. B) Coommasie blue staining shows similar levels of POC5 expression in wt and POC5<sup>A429V</sup> transfected samples. POC5 is observed at the expected size 63kDa. Also the heavy and light chains of antibody are observed.

(TIF)

S2 Fig. Phosphorylation state of wtPOC5 and POC5<sup>A429V</sup> at G1 and S phases of cell cycle.

The immunoprecipitated samples were either non treated or treated with alkaline phosphatase and then western blot was performed using POC5 antibody (abcam). The presence or absence of phosphorylation with wtPOC5 and POC5<sup>A429V</sup> is shown at G1 and S phase. POC5 wt is not phosphorylated, but the POC5<sup>A429V</sup> is phosphorylated, and treatment with phosphatase dephosphorylates POC5<sup>A429V</sup> that returns back to the same levels of wtPOC5. Phosphorylation of mutPOC5 is seen at both G1 and S phases.

(TIF)

## Acknowledgments

Proteomics analyses were performed by the Proteomics Platform of the Institute of Research in immunology and Cancer (IRIC) in Montreal, Canada.
## Author Contributions

**Funding acquisition:** Florina Moldovan.

**Investigation:** Florina Moldovan.

**Methodology:** Amani Hassan, Charlotte Zaouter, Sirinart Molidperee, Shunmoogum A. Patten, Florina Moldovan.

**Project administration:** Florina Moldovan.

**Resources:** Florina Moldovan.

**Supervision:** Isabelle Villemure, Florina Moldovan.

**Validation:** Amani Hassan.

**Writing – original draft:** Amani Hassan, Hélène Mathieu, Charlotte Zaouter, Sirinart Molidperee, Edward T. Bagu, Soraya Barchi, Isabelle Villemure, Shunmoogum A. Patten, Florina Moldovan.

**Writing – review & editing:** Stefan Parent, Hélène Mathieu, Charlotte Zaouter, Edward T. Bagu, Soraya Barchi, Isabelle Villemure, Shunmoogum A. Patten, Florina Moldovan.

## References

1. Parent S, Newton PO, Wenger DR. Adolescent idiopathic scoliosis: etiology, anatomy, natural history, and bracing. Instr Course Lect. 2005; 54:529–36. PMID: 15948477.

2. Fadzan M, Bettany-Saltikov J. Etiological Theories of Adolescent Idiopathic Scoliosis: Past and Present. Open Orthop J. 2017; 11:1466–89. https://doi.org/10.2174/1874325001711011466 PMID: 29399224; PubMed Central PMCID: PMCPMC5759107.

3. Burwell RG, Clark EM, Dangerfield PH, Moulton A. Adolescent idiopathic scoliosis (AIS): a multifactorial cascade concept for pathogenesis and embryonic origin. Scoliosis Spinal Disord. 2016; 11:8. https://doi.org/10.1186/s13013-016-0063-1 PMID: 27252984; PubMed Central PMCID: PMCPMC4888516.

4. Adamson AD, Friedrichsen S, Semprini S, Harper CV, Mullins JJ, White MR, et al. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling. Endocrinology. 2008; 149(2):687–94. https://doi.org/10.1210/en.2007-1066 PMID: 18006630; PubMed Central PMCID: PMCPMC2342177.

5. Patten SA, Margaritte-Jeannin P, Bernard JC, Alix E, Labalme A, Besson A, et al. Functional variants of POC5 identified in patients with idiopathic scoliosis. J Clin Invest. 2015; 125(3):1124–8. https://doi.org/10.1172/JCI77262 PMID: 25642776; PubMed Central PMCID: PMCPMC4362221.

6. Xu L, Sheng F, Xia C, Li Y, Feng Z, Qiu Y, et al. Common variant of POC5 is associated with the susceptibility of adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2017. https://doi.org/10.1097/BRS.0000000000002490 PMID: 29189569.

7. Azimzadeh J, Hergert P, Delouvee A, Euteneuer U, Formstecher E, Khodjakov A, et al. hPOC5 is a centrin-binding protein required for assembly of full-length centrioles. J Cell Biol. 2009; 185(1):101–14. https://doi.org/10.1083/jcb.200808082 PMID: 19349582; PubMed Central PMCID: PMCPMC2700515.

8. Dantas TJ, Daly OM, Conroy PC, Tomas M, Wang Y, Lalor P, et al. Calcium-binding capacity of centrin2 is required for linear POC5 assembly but not for nucleotide excision repair. PLoS One. 2013; 8(7): e68487. https://doi.org/10.1371/journal.pone.0068487 PMID: 23844208; PubMed Central PMCID: PMCPMC3699651.

9. Chang CW, Hsu WB, Tsai JJ, Tang CJ, Tang TK. CEP295 interacts with microtubules and is required for centriole elongation. J Cell Sci. 2016; 129(13):2501–13. https://doi.org/10.1242/jcs.186338 PMID: 27185865; PubMed Central PMCID: PMCPMC4958302.

10. Weisz Hubshman M, Broekman S, van Wijk E, Cremers F, Abu-Diab A, Samer K, et al. Whole-exome sequencing reveals POC5 as a novel gene associated with autosomal recessive retinitis pigmentosa. Hum Mol Genet. 2017. https://doi.org/10.1093/hmg/ddx428 PMID: 29272404.

11. Pan J, Seeger-Nukpezah T, Golemis EA. The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies. Cell Mol Life Sci. 2013; 70(11):1849–74. https://doi.org/10.1007/s00018-012-1052-z PMID: 22782110; PubMed Central PMCID: PMCPMC3657316.
12. Satir P. CILIA: before and after. Cilia. 2017; 6:1. https://doi.org/10.1186/s13630-017-0046-8 PMID: 28293419; PubMed Central PMCID: PMCPMC5343305.

13. Pazour GJ, Witman GB. The vertebrate primary cilium is a sensory organelle. Curr Opin Cell Biol. 2003; 15(1):105-10. PMID: 12517711.

14. Mitchison HM, Valente EM. Motile and non-motile cilia in human pathology: from function to phenotypes. J Pathol. 2017; 241(2):294-309. https://doi.org/10.1002/path.4843 PMID: 27859258.

15. Braun DA, Hildebrandt F. Ciliopathies. Cold Spring Harb Perspect Biol. 2017; 9(3). https://doi.org/10.1101/cshperspect.a028191 PMID: 27793968; PubMed Central PMCID: PMCPMC5334254.

16. Powles-Glover N. Cilia and ciliopathies: classic examples linking phenotype and genotype-an overview. Reprod Toxicol. 2014; 48:98-105. https://doi.org/10.1016/j.reprotox.2014.05.005 PMID: 24859270.

17. Grimes DT, Boswell CW, Morante NF, Henkelman RM, Burdine RD, Ciruna B. Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvature. Science. 2016; 352(6291):1341-4. https://doi.org/10.1126/science.aaf6419 PMID: 27284198.

18. Werner S, Pimenta-Marques A, Bettencourt-Dias M. Maintaining centrosomes and cilia. J Cell Sci. 2017; 130(22):3789-800. https://doi.org/10.1242/jcs.203505 PMID: 29142065.

19. Searle BC. Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies. Proteomics. 2010; 10(6):1265-9. https://doi.org/10.1002/pmic.200900437 PMID: 20077414.

20. Gadadhar S, Dadi H, Bodakuntla S, Schnitzler A, Bieche I, Rusconi F, et al. Tubulin glycylation controls primary cilia length. J Cell Biol. 2017; 216(9):2701-13. https://doi.org/10.1083/jcb.201612050 PMID: 28687664; PubMed Central PMCID: PMCPMC5584158.

21. Robbins E, Jentzsch G, Micali A. The centriole cycle in synchronized HeLa cells. J Cell Biol. 1968; 36(2):329-39. PMID: 5638885; PubMed Central PMCID: PMCPMC2107360.

22. La Terra S, English CN, Hergert P, McEwen BF, Sluder G, Khodjakov A. The de novo centriole assembly pathway in HeLa cells: cell cycle progression and centriole assembly/maturation. J Cell Biol. 2005; 168(5):713-22. https://doi.org/10.1083/jcb.200411126 PMID: 15738265; PubMed Central PMCID: PMCPMC2171814.

23. Knodler A, Feng S, Zhang J, Zhang X, Das A, Peranen J, et al. Coordination of Rab8 and Rab11 in primary ciliogenesis. Proc Natl Acad Sci U S A. 2010; 107(14):6346-51. https://doi.org/10.1073/pnas.1002401107 PMID: 20308558; PubMed Central PMCID: PMCPMC2851980.

24. Westlake CJ, Baye LM, Nachury MV, Wright KJ, Ervin KE, Phu L, et al. Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome. Proc Natl Acad Sci U S A. 2011; 108(7):2759-64. https://doi.org/10.1073/pnas.1018823108 PMID: 21273506; PubMed Central PMCID: PMCPMC3041065.

25. Drivas TG, Bennett J. CEP290 and the primary cilium. Adv Exp Med Biol. 2014; 801:519-25. https://doi.org/10.1007/978-1-4614-3209-8_66 PMID: 24664739.

26. Rachel RA, Li T, Swaroop A. Photoreceptor sensory cilia and ciliopathies: focus on CEP290, RPGR and their interacting proteins. Cilia. 2012; 1(1):22. https://doi.org/10.1186/2046-2530-1-22 PMID: 23351659; PubMed Central PMCID: PMCPMC3563624.

27. Acaroglu E, Akel I, Alanay A, Yazici M, Marcucio R. Comparison of the melatonin and calmodulin in paravertebral muscle and platelets of patients with or without adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2009; 34(18):E659-63. https://doi.org/10.1097/BRS.0b013e3181a3c7a2 PMID: 19680092.

28. Roberts SB, Tsirikos AI. Thoracolumbar kyphoscoliosis with unilateral subluxation of the spine and postoperative lumbar spondylolisthesis in Hunter syndrome. J Neurosurg Spine. 2016; 24(3):402-6. https://doi.org/10.3171/2015.6.SPINE15268 PMID: 26588497.

29. Wilson PJ, Morris CP, Anson DS, Occhiodoro T, Bielicki J, Clements PR, et al. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci U S A. 1990; 87(21):8531-5. PMID: 2122463; PubMed Central PMCID: PMCPMC54990.

30. Galligan JJ, Petersen DR. The human protein disulfide isomerase gene family. Hum Genomics. 2012; 6:6. https://doi.org/10.1186/1479-7364-6-6 PMID: 23245351; PubMed Central PMCID: PMCPMC3500226.

31. Kaplan A, Gaschler MM, Dunn DE, Colligan R, Brown LM, Palmer AG 3rd, et al. Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective. Proc Natl Acad Sci U S A. 2015; 112(17):E2245-52. https://doi.org/10.1073/pnas.1500439112 PMID: 25848045; PubMed Central PMCID: PMCPMC4418888.

32. Nishi H, Hashimoto K, Panchenko AR. Phosphorylation in protein-protein binding: effect on stability and function. Structure. 2011; 19(12):1807-15. https://doi.org/10.1016/j.str.2011.09.021 PMID: 22153503; PubMed Central PMCID: PMCPMC3240861.
33. Toshiba S, Hamada H. Roles of cilia, fluid flow, and Ca2+ signaling in breaking of left-right symmetry. Trends Genet. 2014; 30(1):10-7. https://doi.org/10.1016/j.tig.2013.09.001 PMID: 24091059.

34. Shinohara K, Hamada H. Cilia in Left-Right Symmetry Breaking. Cold Spring Harb Perspect Biol. 2017; 9(10). https://doi.org/10.1101/cshperspect.a028282 PMID: 28213464.

35. Huang BK, Choma MA. Microscale imaging of cilia-driven fluid flow. Cell Mol Life Sci. 2015; 72 (6):1095-113. https://doi.org/10.1007/s00018-014-1784-z PMID: 25417211; PubMed Central PMCID: PMCPMC4605231.

36. Uetake Y, Loncarek J, Nordberg JJ, English CN, La Terra S, Khodjakov A, et al. Cell cycle progression and de novo centriole assembly after centrosomal removal in untransformed human cells. J Cell Biol. 2007; 176(2):173-82. https://doi.org/10.1083/jcb.200607073 PMID: 17227892; PubMed Central PMCID: PMCPMC2063937.